Clindamycin Phosphate Injection 2ml: 0.3G / High Quality

• Customization: Available
• Packaging From: 5 Ampoules/Box
• Packaging: Customization
• Model NO.: injection
• Dosage: Ready
• Transport Package: Shipping
• Specification: 2ml: 0.3g
• Trademark: brand
• Origin: China

Product Description

Value-added services:
 1) Packaging design by our team
 2) Registration service by our team
 3) Registration dossier available by our team
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------

 

Clindamycin Phosphate Injection 2ml: 0.3g

Composition:

Each 2ml ampoule contains:

• Clindamycin Phosphate equivalent to Clindamycin 300mg (0.3g)

Description:

Clindamycin Phosphate is a lincosamide antibiotic with broad-spectrum activity against Gram-positive bacteria and anaerobes. It is commonly used for the treatment of serious bacterial infections, particularly those caused by susceptible strains of Staphylococcus, Streptococcus, and Bacteroides species.

Indications:

Clindamycin Phosphate Injection is indicated for the treatment of infections caused by susceptible bacteria, including:

• Respiratory tract infections (pneumonia, lung abscess, empyema, bronchitis)
• Skin and soft tissue infections (cellulitis, abscesses, wound infections)
• Bone and joint infections (osteomyelitis, septic arthritis)
• Gynecological infections (pelvic inflammatory disease, endometritis)
• Intra-abdominal infections (peritonitis, abscesses)
• Septicemia (bacteremia)
• Serious dental infections
• Prophylaxis for surgical infections

Dosage & Administration:

• Adults & Adolescents (≥12 years):
  • 600-1,200mg daily, divided into two to four doses
  • Severe infections may require up to 4.8g/day IV
• Children (≥1 month):
  • 20-40 mg/kg/day IV in divided doses every 6-8 hours
• Neonates (≤1 month):
  • 15-20 mg/kg/day IV in divided doses every 8-12 hours
• Surgical Prophylaxis:
  • 600-900mg IV 30-60 minutes before surgery
• Renal or Hepatic Impairment:
  • No major dose adjustment required, but monitor liver and kidney function.

Administration:

• Intravenous (IV):
  • Dilute with 5% Dextrose Injection or Normal Saline (0.9% NaCl).
  • Administer slow IV infusion over 10-60 minutes.
  • Do NOT administer as an IV bolus.
• Intramuscular (IM):
  • Maximum 600mg per injection site.

Contraindications:

• Hypersensitivity to Clindamycin or Lincomycin.
• History of Clostridium difficile-associated diarrhea.

Precautions:

• Risk of pseudomembranous colitis - discontinue if severe diarrhea occurs.
• Use with caution in hepatic impairment - monitor liver function.
• Avoid prolonged use to prevent superinfection.

Adverse Reactions:

• Gastrointestinal: Nausea, vomiting, diarrhea, abdominal pain, colitis.
• Allergic Reactions: Rash, urticaria, anaphylaxis (rare).
• Injection Site Reactions: Pain, irritation, thrombophlebitis (IV).
• Hepatic: Elevated liver enzymes (ALT, AST).

Drug Interactions:

• Avoid concurrent use with erythromycin (antagonistic effect).
• May enhance the effects of neuromuscular blockers.
• May interfere with live bacterial vaccines.

Storage Conditions:

• Store below 25°C, protect from light.
• Keep out of reach of children.